Concepedia
Statistics
Publications
8
Citations
535
H-Index
Active since
2015
Affiliations
Hebrew University of Jerusalem(Current)
D. E. Shaw Research
Relay Therapeutics (United States)
Columbia University
Xiamen University
Dina A. Sharon is an author at Hebrew University of Jerusalem specializing in biochemistry, targeted cancer therapy, and pharmacy.
Publications per year
2015–2024
Computation Sheds Insight into Iron Porphyrin Carbenes’ Electronic Structure, Formation, and N–H Insertion Reactivity
Dina A. Sharon, Dibyendu Mallick, Binju Wang et al. · Journal of the American Chemical Society · 2016 · 124 citations
Natural Sciences, Biochemistry, Chemistry +17
RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across <i>FGFR2</i> Alterations and Resistance Mutations
Vivek Subbiah, Vaibhav Sahai, Dejan Maglic et al. · Cancer Discovery · 2023 · 119 citations · Full text
Medicine, Oncology, Pharmacology +16
Selective Chlorination of Substrates by the Halogenase SyrB2 Is Controlled by the Protein According to a Combined Quantum Mechanics/Molecular Mechanics and Molecular Dynamics Study
Jing Huang, Chunsen Li, Binju Wang et al. · ACS Catalysis · 2016 · 91 citations
Pharmacy, Biochemistry, Chemistry +17
Computations Reveal a Rich Mechanistic Variation of Demethylation of <i>N</i>-Methylated DNA/RNA Nucleotides by FTO
Binju Wang, Zexing Cao, Dina A. Sharon et al. · ACS Catalysis · 2015 · 66 citations
Life Sciences, Biochemistry, Molecular Biology +15
Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2
Heike Schönherr, Pelin Ayaz, Alexander M. Taylor et al. · Proceedings of the National Academy of Sciences · 2024 · 66 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +14
1–5 of 8